These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18586766)
21. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function. Pape L; Ehrich JH; Offner G Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963 [TBL] [Abstract][Full Text] [Related]
22. High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis. Schaier M; Scholl C; Scharpf D; Schmitt WH; Schwenger V; Zeier M; Sommerer C Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i138-45. PubMed ID: 25805745 [TBL] [Abstract][Full Text] [Related]
23. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065 [TBL] [Abstract][Full Text] [Related]
24. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients. Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft. Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332 [TBL] [Abstract][Full Text] [Related]
26. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis. Kazderova M; Jancova E; Rysava R; Merta M; Tesar V Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis. Kittanamongkolchai W; Rukrung C; Supasiri T; Lertjirachai I; Somparn P; Chariyavilaskul P; Avihingsanon Y Lupus; 2013 Jun; 22(7):727-32. PubMed ID: 23651860 [TBL] [Abstract][Full Text] [Related]
28. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Tredger JM; Brown NW; Adams J; Gonde CE; Dhawan A; Rela M; Heaton N Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases. Sokumbi O; el-Azhary RA; Langman LJ J Am Acad Dermatol; 2013 Jan; 68(1):36-40. PubMed ID: 22884445 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients. Hummel M; Yonan N; Ross H; Miller LW; Sechaud R; Balez S; Koelle EU; Gerosa G; Clin Transplant; 2007; 21(1):18-23. PubMed ID: 17302587 [TBL] [Abstract][Full Text] [Related]
31. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience. Zakliczyński M; Szewczyk M; Zakliczyńska H; Zembala M Ann Transplant; 2005; 10(2):38-45. PubMed ID: 16218032 [TBL] [Abstract][Full Text] [Related]
32. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Jain AB; Hamad I; Zuckerman S; Zhang S; Warty VS; Fung JJ; Venkataramanan R Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348 [TBL] [Abstract][Full Text] [Related]
34. Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients with gastrointestinal intolerance to mycophenolate mofetil. Sánchez Fructuoso A; Calvo N; Moreno MA; Giorgi M; Conesa J; Barrientos A Transplant Proc; 2007 Sep; 39(7):2194-6. PubMed ID: 17889135 [TBL] [Abstract][Full Text] [Related]
35. The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Mudge DW; Atcheson B; Taylor PJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Nicol DL; Pillans PI; Johnson DW Transplantation; 2004 Jan; 77(2):206-9. PubMed ID: 14742982 [TBL] [Abstract][Full Text] [Related]
36. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Filler G; Foster J; Berard R; Mai I; Lepage N Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy. Muller H; Solari S; Zuniga C; Guerra I; Troncoso J; Ovalle R; Morente J; Pedreros C Transplant Proc; 2007 Apr; 39(3):596-9. PubMed ID: 17445553 [TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Koukoulaki M; Jayne DR Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784 [TBL] [Abstract][Full Text] [Related]
39. Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. Zabotti A; Baraldo M; Quartuccio L; Sacco S; De Marchi G; De Vita S Clin Rheumatol; 2015 Jan; 34(1):171-4. PubMed ID: 25249327 [TBL] [Abstract][Full Text] [Related]
40. The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation. Borrows R; Chusney G; Loucaidou M; James A; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D Ther Drug Monit; 2007 Feb; 29(1):122-6. PubMed ID: 17304160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]